• Home
  • Over
    • Over Panaxea
    • Ons team
    • Vacatures
  • Onze services
    • Health Technology Assessment
    • Health Services & Systems Research
    • Health Innovation Assessment Consultancy
  • News & Cases
  • Publicaties
  • Contact
health economic model

A large provider of haemodialysis services wanted to increase the market share of one of their products. They requested Panaxea 1) to develop a health economic value story to secure global reimbursement for this technology; 2) and to develop a model incorporating both a cost-effectiveness and budget impact analysis to support this dossier. A value story concerning the effectiveness of both treatment modalities was written following an extensive literature review. Based on this we developed a Markov model to project costs, reimbursement and adverse events over a time horizon of five years. The model allows all input parameters to be changed, to make the model match closely to the decision makers population characteristics, reimbursement and cost patterns.

[su_document url=”http://panaxea.nl/wp-content/uploads/2014/01/Value-story-HDF-adapted1.pdf”]

Panaxea b.v. supports decision making in healthcare by assessing the relative advantage of healthcare innovations. Our clients include patients, health and life science innovators and investors, health technology adopters, public and private payers, and policymakers.

Follow us on Twitter

Tweets by @PANAXEA

Useful Links

Home
About Panaxea
Services
Publications
Contact Us

Social Media

 Twitter Linkedin

Contact Informatie

PANAXEA b.v.
Matrix II, unit 1.10
Science Park 400
1098 XH Amsterdam
The Netherlands

+31 20 7400 778
www.panaxea.eu
info@panaxea.eu

© 2019 Panaxea. All Rights Reserved.